IFNG and hemophagocytic syndrome: Monoclonal antibodies against the IL-6 receptor, IFNγ and Janus kinases 1 and 2 (which act downstream of the cytokines) are being tested as an immunomodulatory treatment for HLH (81, 163, 168, 169).